Advanced Search
Reset

Day 1 (2018-06-30)

08:30
10:30
Pre-Congress Workshop: Evidence for exercise and physical activity in solid organ transplant
N-107/108
120.1 Introductions and Opening Remarks
Marcelo Cantarovich, Canada
Chris Thomas, Australia
120.2 Physical impairments in solid organ transplant candidates and recipients – what is the impact on transplant outcomes?
Sunita Mathur, Canada
120.3 Evidence for pre-habilitation and rehabilitation in solid organ transplantation
Tania Janaudis-Ferreira, Canada
120.4 Models of integrating regular physical activity into post-transplant care
Ka Foon Chau, Hong Kong
11:00
12:30
Pre-Congress Workshop: World Transplant Games Federation – Fit for Life!
N-107/108
121.1 Launch of the fit for life toolkit: A tool for engaging transplant recipients in a physically active lifestyle
Chris Thomas, Australia
121.2 The role of technology in encouraging the transplant community to take the first steps to a life of movement
Liz Schick, Switzerland
13:30
15:00
Pre-Congress Workshop: Transplant Recipients Leading their Peers in Physical Activity
N-107/108
122.1 How Fit for Life and Billion Steps Challenge brings together the Canadian transplant community
Claude JA Laflamme, Canada
122.2 Taking exercise to the extreme – what are the limitations for transplant recipients
Gerardo Reyna, Spain
122.3 Patient partnerships in research and knowledge translation: Experience from the CAN-RESTORE network
Sunita Mathur, Canada
Tania Janaudis-Ferreira, Canada
15:30
17:30
Pre-Congress Workshop: High-performance athletes and sports participation post-transplantation
N-107/108
123.1 Sports participation in transplant athletes
Sheila Leddington-Wright, United Kingdom
123.2 10 years of Transplantoux in Belgium – an integrated approach
Diethard Monbaliu, Belgium
123.3 Volvo Ocean Race 2017: Transplant athlete preparation and participation (ending with the BBC video)
Paul N Harden, United Kingdom
123.4 Program wrap-up
Marcelo Cantarovich, Canada
Chris Thomas, Australia
08:30
10:00
Pre-Congress Workshop: Increasing Leadership of Women in Transplantation: Challenges and Solutions
N-111
130.1 Tools for leadership success
Lori J. West, Canada
130.2 Creating a culture of support not competition
Lisa A Robinson, Canada
Panel discussion
Spanish Secretary of Health, -
10:30
12:00
Pre-Congress Workshop: Why is Advocacy needed? Gender disparities in transplantation
N-111
131.1 Gender disparities in access to transplantation
Anette Melk, Germany
131.2 A Bioethics perspective on gender disparities in transplantation
Germaine Wong, Australia
Panel discussion
,
13:30
15:00
Pre-Congress Workshop: Research on issues of Sex and Gender in Transplantation
N-111
132.2 Immunological consequences of pregnancy and impact of subsequent transplantation
Anita Chong, United States
132.3 Impact of the H-Y antigen on solid organ transplant outcomes
Stefan G. Tullius, United States
Panel discussion
,
15:30
17:30
Pre-Congress Workshop: Creating a Culture of success & steps to improve equity
N-111
133.1 How is the new generation tacking gender equity in transplantation?
Maria Irene Bellini, United Kingdom
133.2 Improving gender equity in transplantation: what can professional societies do?
Vassilios Papalois, United Kingdom
133.3 Gender disparities in academia—how does transplantation compare with other fields?
Deborah Adey, United States
Panel discussion
,
08:30
10:00
Pre-Congress Workshop: Immune Monitoring in the Real World
N-112
140.1 Introduction & experience in the ONE Study
Edward K. Geissler, Germany
140.2 Pitfalls and lessons from the ONE Study and beyond
Birgit Sawitzki, Germany
140.3 Designing novel mechanistic studies in clinical trials
Carla C. Baan, Netherlands
140.4 Questions and Answer
Shane T. Grey, Australia
10:30
12:30
Pre-Congress Workshop: Standardization and Success
N-112
141.1 Biobanking in transplantation
Maria Kaisar, United Kingdom
141.2 Measuring donor-reactive T cells for clinical trials and metrics to measure success
Qizhi Tang, United States
141.3 How reliable is your assay? Approaches to standardize and harmonize immune monitoring in clinical trials
Megan Levings, Canada
141.4 Challenges in setting up and running a Treg trial
Fadi Issa, United Kingdom
141.5 Questions and Answer
Shane T. Grey, Australia
13:30
15:00
Pre-Congress Workshop: Session 1
N-112
150.1 Innate vs. adaptive immunity in cell transplant tolerance
Maria Koulmanda, United States
150.2 Pros and cons of using human stem cell derived b-cells for the treatment of diabetes
Klearchos K Papas, United States
150.3 Hepatocytes and mesenchymal stem cells as therapeutic options for the treatment of liver diseases, lessons from animal models
Peggy Stock, Germany
15:30
17:00
Pre-Congress Workshop: Session 2
N-112
151.1 From translational research to clinical application: Where the rubber hits the road
Giuseppe Pettinato, United States
151.2 Neonatal donors for hepatocyte transplantation
Ewa Ellis, Sweden
151.3 Therapeutic potential of placenta-derived stem cells for liver diseases
Toshio Miki, United States

Day 2 (2018-07-01)

08:30
08:40
Pre-Congress Workshop: Welcome Message
N-105
220.1 Welcome Address
Nassim Kamar, France
08:40
10:10
Pre-Congress Workshop: Donor-Derived Infections and Organ Vigilance Around the World
N-105
221.1 Donor-derived infection cases (2 cases)
Nicole M. Theodoropoulos, United States
221.2 Organ vigilance: Background and US perspective
Cameron Wolfe, United States
221.3 Organ vigilance: EU perspective
Sophie Lucas-Samuel, France
221.4 Organ vigilance: Australian perspective
Helen I. Opdam, Australia
221.5 Organ vigilance: Global/WHO perspective
José Ramón Núñez, Switzerland
10:15
11:00
Pre-Congress Workshop: Transplant ID – Lessons Learned from Current Literature
N-105
222.1 Top 10 papers in transplant infectious diseases
Camille Kotton, United States
222.2 Case 1
Michele I. Morris, United States
11:30
13:00
Pre-Congress Workshop: Controversies in Transplant Infectious Diseases: The Expert Showdown
N-105
223.1 Use of HCV positive donors - Pro
Jose Maria Morales, Spain
223.2 Use of hepatitis C positive donors - Con
Jay Fishman, United States
Debate Discussion
,
223.3 Use of donors with multi-drug resistant organisms
Paolo A. Grossi, Italy
Panel Discussion
,
223.5 HIV transplantation
Elmi Muller, South Africa
14:00
16:00
Pre-Congress Workshop: Addressing the Threat of Infections Post-Transplant
N-105
224.1 Prevention and treatment of CMV
Francisco M Marty, United States
224.2 BK virus nephropathy
Brian J. Nankivell, Australia
224.3 New options in the management of multi-drug resistant bacteria
Jean Ralph Zahar, France
224.4 Parasitic infections: Prevention, diagnosis and management
Alice Song, Brazil
224.5 Diarrhea in transplantation
Diana Florescu, United States
16:30
17:30
Pre-Congress Workshop: Cows and Zebras: Challenging Cases in Transplantation
N-105
225.1 Case 2
Edward A Dominguez, United States
225.2 Case 3: Liver transplantation for fulminant hepatitis due to yellow fever
Alice Song, Brazil
225.3 Case 4
Michael G. Ison, United States
09:00
09:10
Pre-Congress Workshop: Welcome and Overview of Organ Trafficking
N-106
230.1 Welcome and overview of organ trafficking
Dominique E. Martin, Australia
Elmi Muller, South Africa
09:10
10:30
Pre-Congress Workshop: Evaluating Prospective Living Donors and Transplant Recipients
N-106
231.1 Case presentations: Learnings from suspected cases of attempted organ trafficking involving resident patients - SOUTH AFRICA
Elmi Muller, South Africa
231.2 Case Presentations: Learnings from suspected cases of attempted organ trafficking involving resident patients - INDIA
Sanjay S. Nagral, India
231.3 Case Presentations: Learnings from suspected cases of attempted organ trafficking involving resident patients - NEW ZEALAND
Ian D Dittmer, New Zealand
231.4 Case Presentations: Learnings from suspected cases of attempted organ trafficking involving resident patients - MEXICO
Rafael Reyes-Acevedo, Mexico
Panel Discussions
,
231.5 Case presentations: Learnings from suspected cases of attempted organ trafficking involving non-resident patients - SPAIN
Beatriz Dominguez-Gil, Spain
231.6 Case presentations: Learnings from suspected cases of attempted organ trafficking involving non-resident patients - PHILIPPINES
Benita Padilla, Philippines
231.7 Case presentations: Learnings from suspected cases of attempted organ trafficking involving non-resident patients - COSTA RICA
Amalia Matamoros, Costa Rica
Panel Discussions
,
10:30
11:00
Pre-Congress Workshop: Suggested Strategies for Preventing and Managing Organ Trafficking in the Clinical Setting
N-106
232.1 Psychosocial evaluation-getting the essential elements right and tailoring to the local environment
Dominique E. Martin, Australia
232.2 Communicating concerns with other transplant programs while respecting patients' rights to privacy and confidentiality
Mona Alrukhaimi, United Arab Emirates
11:30
13:00
Pre-Congress Workshop: Managing Patients Who Returns After Transplantation Aboard that May Have Involved Organ Trafficking
N-106
233.1 Potential indicators of organ trafficking
Jacob Lavee, Israel
233.2 Clinical issues in management-medical
Gabriel Danovitch, United States
233.3 Clinical issues in management-surgical
Riadh A.S. Fadhil, Qatar
233.4 Ethical issues in management
Alexander M Capron, United States
233.5 Building systems to support management
Marta López-Fraga, France
General Discussion
,
14:00
16:00
Pre-Congress Workshop: Welcome and Introduction to the Declaration of Istanbul Custodian Group
N-106
234.1 Welcome from DICG co-chairs
Elmi Muller, South Africa
Dominique E. Martin, Australia
234.2 A brief history of The Declaration and its development
Jeremy R. Chapman, Australia
234.3 The Declaration of Istanbul and DICG in action- achievements and impact
Beatriz Dominguez-Gil, Spain
234.4 Updating The Declaration- a review of the public consultation
Dominique E. Martin, Australia
234.5 Introducing the 2018 Edition of the Declaration of Istanbul
Alexander M Capron, United States
234.6 Implications of the update internationally - TTS (The Transplantation Society)
Nancy Ascher, United States
234.7 Implications of the update internationally - ISN (International Society of Nephrology)
David Harris, Australia
234.8 Implications of the update internationally - WHO (World Health Organization)
José Ramón Núñez, Switzerland
16:30
17:30
Pre-Congress Workshop: Implications of the Update at the Regional Level
N-106
235.1 Oceania
Philip J. O'Connell, Australia
235.2 Africa
Elmi Muller, South Africa
235.3 Asia
Benita Padilla, Philippines
235.4 Europe
Axel Rahmel, Germany
235.5 Latin America
Rudolf Garcia-Gallont, Guatemala
235.6 Middle-East
Mona Alrukhaimi, United Arab Emirates
235.7 North America
Gabriel Danovitch, United States
235.8 Wrap-up by DICG Co-Chairs
Elmi Muller, South Africa
Dominique E. Martin, Australia
09:00
11:00
Pre-Congress Workshop: Xeno-Part 1
N-111
240.1 Survival of Pig Organs in Nonhuman Primates: An Update
David K.C. Cooper, United States
240.2 Pathology of acute and subacute/chronic xenograft rejection
Akira Shimizu, Japan
240.3 Treatment of acute humoral rejection: Lessons learned from allotransplantation
Manuel A. Pascual, Switzerland
240.4 Is PERV a real risk, and should it be eliminated?
Linda Scobie, United Kingdom
11:30
13:00
Pre-Congress Workshop: Xeno-Part II
N-111
241.1 Production of genetically-engineered pigs using new tools
Eckhard Wolf, Germany
241.2 Xenotransplantation of hepatocytes, an alternative to liver transplantation for acute liver failure?
Léo Hans Bühler, Switzerland
241.3 China and xenotransplantation: an update
Shaoping Deng, P.R. China
10:00
11:00
Pre-Congress Workshop: Solid Organ Transplant Immunology
N-112
250.1 Basic immunology core
Caner Süsal, Germany
250.2 Clinical immunology core
Sukru H. Emre, United States
11:00
11:30
Pre-Congress Workshop: Intestinal Transplantation
N-112
251.1 Intestinal transplant core and patient care
Gabriel E. Gondolesi, Argentina
11:30
12:30
Pre-Congress Workshop: Kidney and Pancreas
N-112
252.1 Kidney/pancreas core
Peter I. Abrams, United States
252.2 Specific issues in kidney/pancreas transplant
Peter G. Stock, United States
14:00
15:00
Pre-Congress Workshop: Liver Transplantation
N-112
253.1 Medical
AnneMarie Liapakis, United States
253.2 Surgical
Sukru H. Emre, United States
15:00
16:30
Pre-Congress Workshop: Comprehensive Care of the Transplant Patient
N-112
254.1 Psychological considerations, special population, role of transplant coordinators and social workers and multidisciplinary communications
Joyce A Trompeta, United States
Q&A discussion
,
16:30
17:00
Pre-Congress Workshop: Lung Transplantation
N-112
255.1 Specific issues in lung transplant
Christopher Wigfield, United States
14:00
15:10
Pre-Congress Workshop: Cutting Edge Developments in Paediatric Solid Organ Transplantation
N-111
270.1 Review of key paediatric clinical transplant papers in the last 2 years
Burkhard Tönshoff, Germany
270.2 Review of key basic science papers/developments in the last 2 years
Stephen Alexander, Australia
15:15
16:00
Pre-Congress Workshop: Endocrine and Metabolic Challenges following Paediatric Solid Organ Transplantation
N-111
271.1 Obesity, metabolic syndrome, PTDM following transplant in childhood
Mignon McCulloch, South Africa
16:15
17:30
Pre-Congress Workshop: Challenges to Long Term Survival following Paediatric Solid Organ Transplantation
N-111
272.1 Adherence intervention trials
Anne Dipchand, Canada
272.2 Tumor risk following solid organ transplantation in childhood
George V. Mazariegos, United States


© 2018 TTS2018